NCT06924216

Brief Summary

A randomized clinical trial aims to evaluate the clinical and radiographic outcomes of the repair of congenital alveolar clefts using Iliac crest graft with and without mixing with platelet-rich fibrin

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 27, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 11, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

March 12, 2025

Last Update Submit

April 4, 2025

Conditions

Keywords

alveolar cleftsiliac crestgraftPRF

Outcome Measures

Primary Outcomes (1)

  • Changes in bucco-lingual thickness of the bone at the recipient site

    Post-operative cone beam computed tomographic radiographs will be done using the Scanora 3DX imaging system using a CMOS flat panel detector with isotropic voxel size 133 µm. The x-ray tube that is used to scan the patients possesses a current intensity of 10 mA, 90 KVp, and a focal spot size of 0.5 mm. The scanning time is 14 seconds of pulsed exposure, resulting in an effective exposure time of 3.2 seconds to scan FOV (field of view) of 14 cm height × 16.5 cm width. The raw DICOM data set images will be imported to the On-Demand software (Cybermed, Seoul, Korea) for secondary reconstruction and image analysis. CBCT will be performed, and linear measurements will be obtained in axial, sagittal, and coronal cuts to assess the changes in buccolingual thickness of the bone at the recipient site 3 months and 6 months post-operatively.

    3 months and 6 months postoperatively

Secondary Outcomes (2)

  • Calculation of the volume of bone fill in the recipient site

    6 months postoperative

  • wound dehiscence

    immediate, 7 days and 14 days postoperative

Study Arms (2)

with platelet-rich fibrin

EXPERIMENTAL

study group: the patients will be treated with iliac crest bone graft with platelet-rich fibrin

Procedure: alveolar bone grafting Plus Platelet rich fibrin

without Platelet-rich fibrin

ACTIVE COMPARATOR

control group : the patients will be treated with iliac crest bone graft only

Procedure: alveolar bone grafting

Interventions

cancellous iliac crest bone will be harvested following the usual surgical procedure. For patients of group a-PRF, it was mixed with 1 cc of the supernatant previously collected, in order to obtain a cohesive bone graft, easier to manipulate. The oral mucosal lining will be closed, and a membrane of PRF (PRF group) will be put over the suture line. The alveolar cleft will be then filled with cancellous iliac crest bone along its entire height. A new membrane of PRF will be placed over the bone graft, in order to enclose and protect it. Finally, muco-periosteal flaps will be advanced and sutured without tension over the alveolar crest

Also known as: Repair of alveolar clefts
without Platelet-rich fibrin

the PRF group: centrifugation at 1300 rpm during 5 minutes, collection of 1 cc of the supernatant, and centrifugation at 1300 rpm during 3 minutes. Careful removal of the clot and separation from the red blood cell fraction with scissors. the Platelet-rich fibrin will be added to the surgical site mixed with the iliac crest bone graft and it will also be used as a membrane before closure of the mucoperiosteal flap

Also known as: PRF
with platelet-rich fibrin

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with congenital alveolar cleft who need secondary alveolar cleft repair.
  • Patients who are medically fit for surgery under general anaesthesia

You may not qualify if:

  • ASA 4 OR ASA 5 patients
  • Uncooperative patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal University

Ismailia, 41522, Egypt

Location

Related Publications (1)

  • Bayerlein T, Proff P, Heinrich A, Kaduk W, Hosten N, Gedrange T. Evaluation of bone availability in the cleft area following secondary osteoplasty. J Craniomaxillofac Surg. 2006 Sep;34 Suppl 2:57-61. doi: 10.1016/S1010-5182(06)60013-9.

    PMID: 17071393BACKGROUND

MeSH Terms

Conditions

Alveolar Bone Loss

Interventions

Alveolar Bone Grafting

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Orthognathic Surgical ProceduresOral Surgical ProceduresSurgical Procedures, OperativeOsteotomyOrthopedic ProceduresDentistry

Study Officials

  • Mohamed S Hamed, professor

    Suez Canal University

    STUDY DIRECTOR
  • Osama Antar, professor

    Suez Canal University

    STUDY DIRECTOR
  • Mohamed A Elsholkamy, professor

    Suez Canal University

    STUDY DIRECTOR
  • Mohamed Nageh, Dr

    Suez Canal University

    STUDY DIRECTOR
  • Aliaa E Ebrahim

    Suez Canal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2025

First Posted

April 11, 2025

Study Start

April 27, 2024

Primary Completion

June 1, 2025

Study Completion

December 1, 2025

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations